Company / Free Cash Flow per Share
Arbutus Biopharma Corp Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.21
FY2025
5-year range
-$0.76 / -$0.21
FY2021-FY2025
Trend
+45.5%
vs FY2024
Sector context
#74 of 192
Health Care
What the data says
At $-0.21, Arbutus Biopharma Corp's free cash flow per share ranks #74 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.24 in FY2019 to $-0.21 in FY2025.
Based on SEC 10-K filings.
-0.21 in FY2025.
Improved from $-0.55 to $-0.21 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#74 of 192 in Health CareTop 39% of 192This company -$0.21 Sector average -$19.84
▼
+98.9% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 45.5% year-over-year.
- Ranks #74 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.21 | +45.5% |
| FY2024 | -$0.38 | +30.7% |
| FY2023 | -$0.55 | -123.2% |
| FY2022 | -$0.25 | +67.5% |
| FY2021 | -$0.76 | +31.0% |
| FY2020 | -$1.11 | +11.1% |
| FY2019 | -$1.24 | -22.4% |
| FY2018 | -$1.02 | -0.0% |
| FY2017 | -$1.02 | +10.0% |
| FY2016 | -$1.13 | -5.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026